Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRTK
3426
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $267K | ﹤0.01% |
59,447
+39,919
| +204% | +$189K |
|
3427
Preformed Line Products
PLPC
$1.8B
| $266K | ﹤0.01% |
4,099
+2,375
| +138% | +$155K |
|
3428
Teekay
TK
$1.02B
| $265K | ﹤0.01% |
84,347
+49,117
| +139% | +$169K |
|
|
CEQP
3429
DELISTED
Crestwood Equity Partners LP
CEQP
| $265K | ﹤0.01% |
9,603
+171
| +2% | +$4.76K |
|
3430
PUT
The GEO Group
GEO
$4.11B
| $264K | ﹤0.01% |
34,000
| – | – |
|
3431
Mustang Bio
MBIO
$4.32M
| $263K | ﹤0.01% |
211
+91
| +76% | +$147K |
|
3432
Puma Biotechnology
PBYI
$398M
| $263K | ﹤0.01% |
86,687
+23,044
| +36% | +$100K |
|
|
GTYH
3433
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $262K | ﹤0.01% |
39,069
+24,643
| +171% | +$175K |
|
3434
Gold Fields
GFI
$29B
| $261K | ﹤0.01% |
23,717
-226,794
| -91% | -$2.26M |
|
3435
UroGen Pharma
URGN
$1.9B
| $261K | ﹤0.01% |
27,459
+15,699
| +133% | +$221K |
|
3436
PUT
GSK
GSK
$104B
| $260K | ﹤0.01% |
4,720
| – | – |
|
3437
Legacy Housing
LEGH
$624M
| $259K | ﹤0.01% |
9,762
+5,493
| +129% | +$123K |
|
|
SIEN
3438
DELISTED
Sientra, Inc.
SIEN
| $259K | ﹤0.01% |
7,047
+4,418
| +168% | +$214K |
|
|
KG
3439
Kestrel Group
KG
$67.1M
| $258K | ﹤0.01% |
4,219
+2,798
| +197% | +$177K |
|
3440
Pilgrim's Pride
PPC
$6.62B
| $258K | ﹤0.01% |
9,153
-77,508
| -89% | -$2.21M |
|
3441
Future Fuel
FF
$215M
| $257K | ﹤0.01% |
33,748
+12,558
| +59% | +$97.4K |
|
3442
CALL
Consolidated Edison
ED
$40.4B
| $256K | ﹤0.01% |
3,000
| – | – |
|
3443
Kodak
KODK
$804M
| $255K | ﹤0.01% |
54,462
+36,121
| +197% | +$227K |
|
3444
TORM
TRMD
$3.1B
| $255K | ﹤0.01% |
32,164
-45,961
| -59% | -$367K |
|
|
ROCC
3445
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $255K | ﹤0.01% |
+9,457
| New | +$278K |
|
|
SCHW
3446
PUT
Charles Schwab
SCHW
$183B
| $254K | ﹤0.01% |
3,024
| – | – |
|
3447
SandRidge Energy
SD
$504M
| $254K | ﹤0.01% |
24,276
-12,537
| -34% | -$149K |
|
3448
Security National Financial
SNFCA
$243M
| $254K | ﹤0.01% |
35,293
-1,664
| -5% | -$11.4K |
|
|
FRGI
3449
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $253K | ﹤0.01% |
23,005
+4,425
| +24% | +$47.3K |
|
3450
POSCO
PKX
$16.1B
| $251K | ﹤0.01% |
4,301
| – | – |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.